Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
U.S. Stocks
CFD
U.S. stock CFD derivatives
Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
GUSD
Mint GUSD for Treasury RWA yields
Earn
Launch
CandyDrop
tag
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
Gate Card
Rewards
Square
Latest
Hot
News
Profile

Chen-Zuckerberg Initiative Launches an AI Drug Discovery World Model, Free for Researchers Worldwide

MeNews
robot
Abstract generation in progress
AIMPACT News, May 27 (UTC+8), Chen-Zuckerberg Initiative announced the launch of an artificial intelligence world model for drug research and development. The model aims to help researchers better understand biological systems, accelerate the drug discovery process, and will be freely available to scientific researchers. As a charitable organization jointly founded by Zuckerberg and his wife Priscilla Chan, the Chen-Zuckerberg Initiative stated that this project is part of their ongoing investment in science and medicine, hoping to leverage AI technology in biomedical research to provide innovative solutions to global health challenges and promote the development of medical research and public health initiatives.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 5
  • 2
  • Share
Comment
Add a comment
Add a comment
Stop-LossIsLikeAConfession
· 8h ago
Free AI models? Hopefully, they won't get shut down halfway through by regulators like Libra.
View OriginalReply0
GateUser-e72657f0
· 13h ago
Medical data is sensitive; how to solve cross-border flow issues? This announcement doesn't seem to mention it.
View OriginalReply0
GateUser-eb706989
· 18h ago
In biological system modeling, data quality is more important than the model architecture.
View OriginalReply0
VinylRadioProphecy
· 19h ago
The new drug development cycle is too long; AI can at least shorten the preclinical stage, thank goodness.
View OriginalReply0
AirdropNightwatch
· 19h ago
Zuckerberg’s strategic shift has truly opened up the bigger picture—pharmaceutical R&D really does need this kind of open infrastructure.
View OriginalReply0

  • Pinned

Sitemap